Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|September 8, 2001
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancerE Kapiteijn, C A Marijnen, I D Nagtegaal, et al.
International Journal of Endocrinology|August 22, 2015
Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II TrialT C Schneider, D de Wit, T P Links, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2016
Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancerD de Wit, T C Schneider, D J A R Moes, et al.
Cardiovascular and Interventional Radiology|August 3, 2022
Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled AnalysisT M L Tong, M Samim, E Kapiteijn, et al.
European Journal of Endocrinology|January 23, 2019
Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinomaK van der Tuin, M Ventayol Garcia, W E Corver, et al.
British Journal of Cancer|January 9, 2023
A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanomaS Piperno-Neumann, M S Carlino, V Boni, et al.
European Journal of Radiology|July 8, 2025
Cost-effectiveness of [<sup>18</sup>F]FDG PET/CT in follow-up after thermal ablation in patients with colorectal liver metastases in the Dutch healthcare settingS van Mossel, O D Bijlstra, F A van Delft, et al.
Trials|February 14, 2022
Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trialT M L Tong, M K van der Kooij, F M Speetjens, et al.
Cardiovascular and Interventional Radiology|April 8, 2024
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver MetastasesT M L Tong, M Fiocco, J J van Duijn-de Vreugd, et al.
Cardiovascular and Interventional Radiology|January 9, 2023
Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin TrialT M L Tong, M C Burgmans, F M Speetjens, et al.
Pageof 5